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ABSTRACT
ClusterCAD is a web-based toolkit designed to lever-
age the collinear structure and deterministic logic
of type I modular polyketide synthases (PKSs) for
synthetic biology applications. The unique organi-
zation of these megasynthases, combined with the
diversity of their catalytic domain building blocks,
has fueled an interest in harnessing the biosyn-
thetic potential of PKSs for the microbial produc-
tion of both novel natural product analogs and in-
dustrially relevant small molecules. However, a lim-
ited theoretical understanding of the determinants
of PKS fold and function poses a substantial bar-
rier to the design of active variants, and identify-
ing strategies to reliably construct functional PKS
chimeras remains an active area of research. In this
work, we formalize a paradigm for the design of PKS
chimeras and introduce ClusterCAD as a computa-
tional platform to streamline and simplify the process
of designing experiments to test strategies for engi-
neering PKS variants. ClusterCAD provides chemi-
cal structures with stereochemistry for the interme-
diates generated by each PKS module, as well as
sequence- and structure-based search tools that al-
low users to identify modules based either on amino
acid sequence or on the chemical structure of the
cognate polyketide intermediate. ClusterCAD can be
accessed at https://clustercad.jbei.org and at http:
//clustercad.igb.uci.edu.
INTRODUCTION
Polyketides and their derivatives are used broadly in
medicine as antibiotics, antifungals and immunosuppres-
sants, among other applications (1), motivating research to
engineer polyketide synthases (PKSs) capable of produc-
ing novel drug analogs. More recently, researchers have also
harnessed the biosynthetic potential of PKSs to produce
commodity chemicals in an environmentally friendly man-
ner (2–4).
Type I modular PKSs are composed of a series of cat-
alytic domains whose identity and order determine the
structure of the final polyketide product in a predictable
manner, as shown in Figure 1. A single PKS can include
multiple polypeptide subunits, each comprising one ormore
modules. Each module, which is minimally made up of a
set of ketosynthase (KS), acyltransferase (AT) and acyl car-
rier protein (ACP) domains, catalyzes the extension of the
nascent acyl chain by two carbon units. This is accom-
plished via a KS-catalyzed decarboxylative condensation
between an acyl starter or intermediate, and a dicarboxylic
acid extender unit, which is selected by the AT (5,6). The re-
sulting -ketone may be reduced by a ketoreductase (KR)
domain, which determines the stereochemistry of the re-
sulting -hydroxyl group, and that of the -substituent,
if present (7–11). Additional dehydratase (DH) and enoyl
reductase (ER) domains may further reduce the hydroxyl
group to yield a methenyl or methylene group, respectively.
The KR, DH and ER make up a set of optional reducing
domains that together, are termed the reductive cassette. In
addition to these reductive domains, C- or O- methyltrans-
ferases may also be present. Release of a polyketide from a
PKS is carried out by a thioesterase (TE) domain that cat-
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Figure 1. Determination of polyketide chemical structure by a sequence of PKS catalytic domains. A loading ATL (blue) selects a starter acyl-CoA and
catalyzes the chain initiation reaction, thereby specifying the identity of the R group in the extension reaction product. This acyl-intermediate is then
transferred to the KS. The AT (blue) selects a malonyl-CoA derivative as an extender unit, which is subsequently transferred to the ACP, determining
the R′ group in the extension reaction product. Next, the KS catalyzes a decarboxylative condensation between the KS bound acyl-intermediate and the
ACP-bound extender unit to yield an ACP-tethered product, with the newly formed C-C bond shown in bold. The ketone located at the  position of the
resulting intermediate may be optionally reduced by a KR to form a hydroxyl group, a DH to form anmethenyl group and an ER to formmethylene group.
The presence or absence of these reductive domains (red) therefore determine the identity of the R′′ group. This poly--ketone may go through multiple
extension steps before reaching a TE, which catalyzes either hydrolysis or cyclization to form an acid or a lactone, respectively.
alyzes either hydrolysis or cyclization. The resulting acid or
lactone may undergo additional modifications to form the
final active compound (12).
The potential interchangeability of PKS catalytic do-
mainsmake PKSs an appealing prospective toolkit for com-
binatorial biosynthesis. The structure of the two-carbon ad-
dition to the nascent acyl chain that is effected by a single
PKSmodule is determined by the substrate specificity of the
AT domain, the stereochemical outcome modulated by the
KR domain, and the number of active reducing domains
in the reductive cassette. Over 20 different malonyl-CoA
analogs have been observed to be used as extender units in
naturally occurring PKSs (3,13,14). Furthermore, all pos-
sible combinations of stereochemical configurations at the
 and  positions are made accessible by different KR do-
mains. Developing methods to effectively recombine exist-
ing PKSs thus offers a tantalizing promise of access to an
expansive region of chemical space.
However, in spite of recent structural and mechanistic
insights gained from structural biology techniques, includ-
ing X-ray crystallography (15–17) and cryo-electron mi-
croscopy (18,19), a comprehensive model of the protein–
protein interactions and catalytic mechanisms that gov-
ern the fold and function of PKS modules remains elu-
sive.Nevertheless, encouraging earlier work has successfully
combined intuition and expert domain knowledge with in-
spection of existing sequence alignments and X-ray crystal
structures to engineer chimeric PKSs harboring a heterol-
ogous AT domain (3,20–22), a heterologous KR domain
(23–25), or a heterologous reductive cassette (2,21,24,26–
28). These results suggest that it is possible to identify com-
binations of junctions and catalytic domains that facilitate
the construction of active PKS chimeras. While codifying
the intuition that has previously enabled successful domain
exchanges is impossible, one commonly used heuristic is to
seek to design a chimeric PKS that is as similar to a nat-
urally occurring PKS as possible. Using this guiding prin-
ciple, we propose the following paradigm for designing a
chimeric PKS capable of producing a small molecule com-
pound of interest:
i) Identify a truncated PKS parent to use as a starting
point for engineering by searching for a module known
to produce a polyketide intermediate with maximal
structural similarity to the compound of interest.
ii) Decompose the difference between the natural product
of the truncated PKS starting point and the compound
of interest into a series of catalytic domain exchanges.
iii) Select donor modules for the required catalytic domain
exchanges on the basis of sequence similarity to the
truncated PKS parent.
ClusterCAD was developed with the aim of enabling the
design of chimeric PKSs following this paradigm. As such,
it includes a structural search tool to facilitate the identifi-
cation of a truncated PKS parent to use as an engineering
starting point given a small molecule target, and a sequence
search tool to aid in the selection of donor modules for cat-
alytic domain exchanges based on sequence similarity to the
truncated PKS parent. However, we emphasize that Clus-
terCAD is intended to augment, rather than supersede, the
biochemical intuition of PKS synthetic biologists.
Sequence similarity between PKS modules, and struc-
tural similarity between their cognate polyketide intermedi-
ates, provide only a rudimentary method of predicting com-
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patibility between PKS polypeptide sequences. It is thus
also important to consider additional factors when design-
ing a chimeric PKS. For example, modules that originate
from well-characterized clusters, or that have been previ-
ously determined to be well-expressed in the host organism
of choice, are particularly attractive choices for engineering.
MATERIALS AND METHODS
Data curation
The gene clusters in ClusterCAD are sourced from the
Minimum Information about a Biosynthetic Gene cluster
(MIBiG) database (29). To construct each ClusterCAD
entry, the gene clusters in version 1.3 (3 September 2016)
of the MIBiG database labeled as type I modular PKSs
were first identified. These gene clusters were annotated
using the antibiotics and Secondary Metabolite Analysis
SHell (antiSMASH) (30), and the resulting output parsed
using a list of explicitly recognized catalytic domains.
Cluster analysis was truncated if a subunit containing an
unrecognized catalytic domain was encountered. Domain
annotations, which include predictions for AT substrate
specificity and KR stereochemical outcome, informed in
silico simulation of biocatalysis using reaction SMARTS
operators (http://www.daylight.com/dayhtml/doc/theory/),
which were implemented using the RDKit cheminfor-
matics software library (http://www.rdkit.org), yielding
a predicted intermediate chemical structure for each
PKS module. Known final chemical structures were
taken from the MIBiG database if available, or were
otherwise generated from the text description of the final
structure in the MIBiG database using the ChemAxon
JChem Base naming tool (version 17.2.27.0, 2017) (31).
Chemical structures for well-characterized polyketide
products that could not be obtained by either of these
methods were manually incorporated. Comparisons of the
predicted and known final product chemical structures,
close inspection of established amino acid sequence motifs
(20,32) and an extensive literature search were used to
manually curate each ClusterCAD entry by correcting
subunit order, removing invalid subunits, accounting for
iterating modules and correcting misannotated catalytic
domain activity. The SCRATCH software suite (33,34) was
used to generate secondary structure and relative solvent
accessibility predictions for the PKS subunits in Cluster-
CAD, which were also incorporated into the database.
Organization
User interface. The primary objective of ClusterCAD is to
provide computational assistance to the synthetic biologist
seeking to engineer PKSs. ClusterCAD provides an intu-
itive interface for users to browse through the clusters in the
database, as well as search tools developed to assist in the
design of chimeric PKSs. An example entry of a PKS clus-
ter as displayed in the ClusterCAD web interface, is shown
in Figure 2.
i) Structure search tool: the structure search tool was de-
signed to enable the identification of a truncated PKS
parent to use as a starting point for PKS engineering,
and takes as input either a small molecule chemical
structure represented as a SMILES string, or a structure
that is drawn in an interactive graphical user interface.
This tool searches a database of the predicted polyketide
intermediates produced by each of the PKS modules in
ClusterCAD.Matches to the query structure are ranked
using atom pair (AP) Tanimoto similarity scores (35),
and returned matches are displayed with the maximum
common substructure (36) between the query and target
structures highlighted.
ii) Sequence search tool: the sequence search tool was de-
signed to enable researchers to select candidate catalytic
domains for domain exchange experiments, and sup-
ports a variety of queries that allow researchers to test
hypotheses regarding which domain–domain interac-
tions may be important in facilitating successful domain
exchanges. The sequence search tool takes as input an
amino acid sequence, and performs a protein–protein
BLAST+ search against a database containing all of the
subunits in ClusterCAD (37). The results page enables
deeper interrogation of the returned results by highlight-
ing catalytic domains on the basis of annotations such
as AT substrate specificity, KR stereochemical outcome,
and reductive domain activity.
DISCUSSION
Motivation behind ClusterCAD
ClusterCAD provides the first PKS database that specif-
ically targets engineering applications. Existing PKS
databases focus on identifying new metabolites through
genome mining or on predicting metabolite structure from
nucleotide or amino acid sequence (38). However, many of
the most promising applications of PKSs are premised on
harnessing their ability to generate customized molecular
architectures.
From an engineering perspective, ClusterCAD offers
substantial improvements over existing databases. By tak-
ing advantage of resources such as the MIBiG database
and the antiSMASH command-line tool for cluster iden-
tification and annotation respectively, we were able to fo-
cus on designing tools tailored to the needs of the synthetic
biologist without attempting to optimize our software for
genomemining ormetabolite structure prediction. Further-
more, given the strong commitment from the synthetic bi-
ology and natural products communities to update MiBiG
and antiSMASH with continuous improvements, populat-
ing ClusterCAD using an end-to-end pipeline that utilizes
these tools means that ClusterCAD can easily be kept up-
to-date as novel biosynthetic clusters are discovered and as
our understanding of PKSs develops.
While building on MiBiG and antiSMASH aids in au-
tomating the maintenance of ClusterCAD, it also means
that inaccuracies in MiBiG or in the antiSMASH software
may be propagated into ClusterCAD. In order to address
this issue, we also employ extensive manual curation of each
ClusterCAD entry in order to provide predicted polyketide
intermediates that are as accurate as possible. ClusterCAD
has a persistent corrections record that overwrites the out-
put generated by antiSMASH. This enables ClusterCAD
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Figure 2. ClusterCAD entry for the borrelidin PKS. The ClusterCAD page for each cluster contains links to the corresponding entries in the MiBiG and
NCBINucleotide databases. Catalytic domain annotations can be optionally displayed based on domain type. Interactive web page elements provide access
to more detailed information, such as the nucleotide and amino acid sequences of each catalytic domain and subunit.
to incorporate new MiBiG entries and systematic improve-
ments to antiSMASH, while also guaranteeing that clus-
ters that have previously been manually corrected will re-
main correct. Because these records are persistent and over-
ride the automatically generated output, the manually cu-
rated clusters will only need to be further corrected if new
empirical findings are generated. ClusterCAD thus com-
bines computational annotations of AT substrate specificity
and KR stereospecificity with domain expert application of
heuristics obtained from the literature (20,32,39,40) to pro-
vide well-curated predictions of the polyketide intermedi-
ates naturally provided by each of the PKSmodules in Clus-
terCAD. However, the reliance on manual curation means
that some errors may be missed. We include links on each
cluster page that can be used to submit corrections to the
ClusterCAD maintainers for review.
ClusterCAD is further limited in that it does not sup-
port inclusion of chemistry effected by ‘on-line’ tailoring
enzymes that act on ACP-tethered polyketide intermedi-
ates, but that are independent of the PKS (41). However,
we believe that showing the direct product of the PKS, with-
out taking into account ‘on-line’ tailoring enzymes provides
the information that is most relevant for engineering, since
‘on-line’ tailoring enzymes are not expected to be naturally
present in a heterologous host.
A substantial benefit of ClusterCAD is that it provides
engineering tools that allow researchers to compare PKS
modules based on amino acid sequence similarity and on
cognate polyketide intermediate similarity. The substruc-
ture search in ClusterCAD is of particular utility when se-
lecting candidate modules to serve as a starting point in a
PKS engineering project. Previous experimental evidence
supports the assertion that the structure of the intermediate
can have a significant impact on the function of individual
catalytic domains. KS domains, for example, have been re-
ported to have ‘gatekeeping’ functionality, in which they are
unable to condense intermediates that are chemically dis-
similar for reasons ranging from overall steric bulkiness (42)
to having an opposite stereochemical configuration (43,44).
Other domains, such as the KR domain (25) and the DH
domain (45) have also been observed to have poor catalytic
activity on substrates that are much smaller or bulkier than
ones they encounter in nature.
The substructure search in ClusterCAD is one of the first
that matches against polyketide intermediates associated
with non-terminal PKS modules, making it more robust to
false positives than similar search tools which only support
substructure queries in the context of PKS final products
(46).Matching directly against the polyketide intermediates
produced by each module also avoids undesirable matches
to structural motifs produced by tailoring enzymes, which
are of limited utility for PKS engineering. To the best of our
knowledge, SBSPKSv2 (47) is the only other PKS database
that supports structure-based queries that match against
polyketide intermediates. However, ClusterCAD boasts a
larger number of type I modular PKS intermediates, and
utilizes AP descriptors, which exhibit greater sensitivity to
uncommon chemical motifs than the substructure finger-
print approach used by SBSPKSv2.
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Further, anecdotal evidence supports the assertion that
seeking catalytic domains with greater sequence similarity
improves domain exchange success rates (25). While this
heuristic is challenging to verify experimentally given the
low throughput of domain exchange experiments, it is our
hope that ClusterCAD will assist PKS researchers in elu-
cidating the importance of sequence similarity in domain
exchange experiments by streamlining the design of experi-
ments to test their hypotheses. For instance, by facilitating
chimeric PKS design, ClusterCAD will enable researchers
to probe potential domain–domain interactions which may
be important for engineering.
The sequence search tool in ClusterCAD highlights the
domains in each returned module that overlap with the
query, and also allows the user to highlight results based
on catalytic domain activity. Identifying junctions in PKS
chimeras that reliably leave functionally important struc-
tural elements intact (24,25) remains an open area of re-
search. ClusterCAD provides secondary structure and rel-
ative solvent accessibility predictions that will aid in the
identification and comparison of homologous structural el-
ements across PKSs, assisting researchers in junction de-
sign. As far as we are aware, ClusterCAD is the only PKS
database that provides precomputed values for the pre-
dicted secondary structure and relative solvent accessibil-
ity of each subunit. By providing support to compare PKS
modules on the basis of metrics that may contribute to
compatibility between PKS polypeptide sequences, Cluster-
CAD aims to facilitate experimental research to identify ro-
bust strategies for PKS engineering.
Using ClusterCAD to design a chimeric PKS that produces
adipic acid
While engineered PKSs have long been an attractive strat-
egy to produce pharmaceutically relevant natural products
and their analogs, more recent work has also sought to har-
ness the chemical diversity accessible by PKS to provide an
environmentally friendly alternative to chemical synthesis
for commodity chemicals. Previouswork byHagen et al. has
demonstrated that it is possible to engineer a novel PKS ca-
pable of producing adipic acid (2), a widely used commodity
chemical. As a proof-of-concept, we describe how Cluster-
CAD could be applied to engineer this novel PKS.
i) Identify a truncated PKS starting point that naturally
produces a polyketide intermediate that is structurally
similar to adipic acid. Hagen et al. selected the first
module from the borrelidin PKS as a starting point
based on previous biochemical studies establishing that
BorMod1 tolerates succinyl-CoA as a starter, possi-
bly because of structural similarity to the native prim-
ing unit, trans-1,2-cyclopentanedicarboxylic acid (48).
Adipic acid was used to query the ClusterCAD chem-
ical structure search tool, which returned BorMod1 as
the highest-scoring result, with a naturally produced in-
termediate that had an AP Tanimoto similarity score of
0.32 when compared against adipic acid.
ii) Identify a donor reductive loop with active ER, DH
and KR from a module which naturally incorporates a
malonyl-CoA extender unit. In order to produce adipic
acid using BorMod1, incorporation of an extender unit
lacking a -substituent and reduction by a full com-
plement of active reducing domains was required. Ha-
gen et al. thus chose four reductive loop donors that
naturally accepted malonyl-CoA, harbored a DH, ER
and KR in the reductive cassette, and that came from a
‘standalone’ module, in which the corresponding open
reading frame or subunit contained only a single mod-
ule. Donor loops from ‘standalone’ modules were fa-
vored based on the intuition that domain exchanges
using reductive cassettes derived from a ‘standalone’
module would retain more architectural similarity to
BorMod1, itself a ‘standalone’ module, and thereby in-
crease the likelihood of a functional chimera.
Using the ClusterCAD sequence search tool, we sought
to identify donor modules that not only met these cri-
teria, but also exhibited maximal sequence similarity
to BorMod1. We queried the ClusterCAD sequence
search tool with the amino acid sequence of BorA2, the
subunit which contains BorMod1, ranking the poten-
tial donor modules by bit score and filtering for ‘stan-
dalone’ modules containing amalonyl-CoA specific AT
and a complete reductive cassette. IdmO, from the in-
danomycin PKS, followed by SpnB from the spinosyn
PKS were the only two returned results that matched
all three criteria. Chimeras utilizing these two donor
modules were experimentally tested by Hagen et al.,
along with chimeras harboring reductive cassettes from
the donor modules AurB, from the aureothin PKS and
NanA2, from the nanchangmycin PKS. AurB, which
is not contained in ClusterCAD, and SpnB were em-
pirically determined to yield the most active chimeras.
NanA2, which was not returned by ClusterCAD, but
is contained in the database, yielded the least active
chimera.
iii) Identify a DH domain that exhibits higher levels of activ-
ity on 3-hydroxy adipic acid. The chimeras constructed
by Hagen et al. yielded a relatively large proportion of
the incompletely reduced product 3-hydroxyadipic acid,
potentially due to theDH from the donor reductive cas-
settes having a poor substrate compatibility with the
terminal carboxyl moiety, an unusual feature in PKS
biosynthetic intermediates. To overcome this substrate
incompatibility, Hagen et al. further substituted a het-
erologous DH into the engineered BorMod1 variant.
The DH from BorMod2 was selected based on the ob-
servation that it is known to demonstrate catalytic activ-
ity on a substrate containing a terminal carboxymoiety.
The intuition employed by Hagen et al. was consistent
with the sequence-similarity based output of the Clus-
terCAD search tool, which returned BorMod2 as the
module containing an active DH that had the highest
bit score with BorMod1.
Implications of ClusterCAD for PKS engineering
As the first PKS database that specifically targets syn-
thetic biologists interested in PKS engineering, we also
sought more generally to provide tools for computer-aided
PKS design, and have released ClusterCAD under a BSD
style license at https://github.com/JBEI/clusterCAD. This
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Figure 3. Partial JSON representation of the borrelidin PKS. This repre-
sentation captures the hierarchical organization of PKSs, as well as the
important catalytic properties of their components.
open source release provides Python object representa-
tions of catalytic domains, modules and clusters, that en-
able researchers to construct and simulate the activity of
chimeric PKSs in silico. Furthermore, we sought to estab-
lish a method to describe PKSs in a human and computer
readable manner using the JSON data-interchange format,
as shown in Figure 3. The availability of such a PKS repre-
sentation will aid in the development of additional software
for computational PKS design by allowing researchers to
easily describe novel PKSs in a computer-readable fashion.
CONCLUSION
To the best of our knowledge, ClusterCAD is the first
web-based toolkit developed specifically to aid in design-
ing chimeric PKSs. By providing chemical structures with
stereochemistry for the polyketide intermediate produced
by each module, as well as relative solvent accessibility and
secondary structure predictions for each subunit, we pro-
vide rich information about each cluster to inform chimeric
PKS design. Furthermore, our intuitive user interface, com-
bined with the ability to query for modules based on either
sequence- or structure-similarity provide powerful tools for
PKS engineering that bring us closer to the promise of har-
nessing PKSs for combinatorial biosynthesis.
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